Partnering & Licensing Opportunities

Arbutus is open to collaborating with partners interested in complementing our research and development efforts.

 

We are focused on developing a cure for patients with hepatitis B through combination therapy and developing treatments for coronaviruses. We intend to accomplish this either with our pipeline of unique products targeting HBV and coronavirus, or by complementing our research and development efforts through collaborations.

We have a portfolio of assets covering multiple HBV mechanisms of action, a robust pipeline of agents delivering near-term catalysts with long-term value creation potential, and a management team with proven scientific leadership in antiviral drug discovery and development.

If you are interested in collaborating with Arbutus, please contact our business development team at bd@arbutusbio.com.